Gordon Bernard, MD
Bernard oversees Vanderbilt University Medical Center's efforts to move research from bench to bedside. He has leadership and oversight responsibility for the offices of the Human Research Protection Program, Office of Contracts Management, the Vanderbilt Institutional Review Board, Clinical Trials Center, the Vanderbilt Institute for Clinical and Translational Research and the Center for Technology Transfer and Commercialization. After receiving a $20 million, five-year federal Clinical and Translational Science Awards (CTSA) grant, Bernard also serves as principal investigator of the CTSA Coordinating Center. He sits on the board of Cumberland Pharmaceuticals and chairs the company's Medical Advisory Board.